Ovid partners with Waksal startup to develop drugs for rare brain disorders
Bio Pharma Dive
MAY 1, 2023
Founded by Sam Waksal, Graviton Biosciences is developing drugs that block an enzyme called ROCK2, which drew the interest of neurology-focused Ovid.
Let's personalize your content